CGEN-34

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCGEN-34
Drug Alias NameANP hormone splice variants (Compugen)CGEN-34
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionAtrial natriuretic peptide receptor agonists
TargetsAtrial natriuretic peptide receptor
Therapy Area/IndicationsCardiovascular DiseasesKidney Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCompugen Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCompugen Ltd
Active IndicationsN/A
Inactive IndicationsCardiovascular DiseasesKidney Diseases

Other Information

ATC CodeN/A
Related LinksN/A